Levitra 20mg (Vilitra) UK Reviews
The active ingredient of Levitra is vardenafil and has been developed by Bayer. The drug has been available since 2003 and is one of the three best-selling potency drugs in the world. Levitra is well tolerated and is effective within 30 minutes. Like Viagra, the effect lasts about 4-6 hours. Vilitra 20 mg is one of the most popular generic drug of Levitra.
What is Levitra and what is it used for?
Levitra is a medicine used to treat men’s erectile dysfunction. The active ingredient of Levitra is Vardenafil. Vardenafil promotes blood flow into the penis just like Sildenafil in Viagra. An erectile dysfunction is defined as the inability to achieve proper or hard enough erection.
10% of men occasionally has problems to get a satisfactory erection. Reasons for this are mostly physical or psychological causes.
How does Levitra work?
While talking about erection, two substances are released in the body:phosphodiesterase-5 (PDE-5) and cyclic guanosine monophosphate (cGMP). CGMP leads to a relaxation of the muscles in the penis, which allows more blood flow into the corpus cavernosum and results to an erection. Cyclic GMP is degraded by the PDE-5. Production and dismantling are normally balanced.
Levitra is an inhibitor of PDE-5. When enzyme PDE-5 is inhibited by Vardenafil, this leads to a strong and long erection.
The advantage of PDE-5 inhibitors is that they only lead to an erection when sexual excitement is present. Vardenafil also flooded faster than Sildenafil, the active ingredient in Viagra. Thus, Levitra often starts effecting after 20 minutes.
Levitra is manufactured by the pharmaceutical company Bayer.
Are there Levitra Generics?
Levitra generics are often found on the Internet. Generics are usually much cheaper than original preparations, although they have the same effect.
What are Generics?
Generics are drugs that contain the same active ingredient as the original drug. As soon as the patent protection of the original product expires, generic drugs can be produced and offered by other manufacturers legally. In contrast to the original, there are no high development costs for the development of generics, so that the selling prices for a generic drug is significantly more favorable. Of course, generic drugs are also subject to strict legal regulations and are intensively tested before having marketing permission. Often, they not only largely correspond to the original, but are further developed and offered in improved dosage forms or formulations.
The oral phosphodiesterase-5 inhibitor Vardenafil in Levitra was researched, developed and launched by the German company Bayer Healthcare in 2003 after approval by the European Commission. Vilitra is a generic form of Levitra.